88IV - Public company info - CARsgen Therapeutics Holdings Limited

Input the stock code or the company name

CARsgen Therapeutics Holdings Limited, 02171.HK - Cash Flow	2021-12	2020-12	2019-12
Net Cash Flow from Operating Activities	-515,890	-295,913	-180,433
Net Cash Flow from Return on Investments & Servicing of Finance	-1,882	-12,683	717
Interest Received	8,803	763	1,429
Interest Paid	-10,685	-13,446	-712
Dividend Received	0	0	0
Dividend Paid	0	0	0
Others	0	0	0
Taxes (Paid) / Refunded	0	0	0
Net Cash Flow from Investing Activities	-2,476,556	-6,897	82,985
Additions to Fixed Assets	-175,841	-17,727	-102,641
Disposal of Fixed Assets	11	0	0
Increase in Investments	0	0	0
Decrease in Investments	0	0	170,142
Net Cash Flow with Related Parties	0	0	0
Others	-2,300,726	10,830	15,484
Net Cash Flow before Financing Activities	-2,994,328	-315,493	-96,731
Net Cash Flow from Financing Activities	2,684,717	1,315,919	28,239
New Loans	293,219	170,000	42,500
Loans Repayment	-162,944	-165,271	-256,386
Fixed Income/Debt Instruments	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0
Equity Financing	2,576,082	0	0
Net Cash Flow with Related Parties	0	0	0
Others	-21,640	1,311,190	242,125
Increase(Decrease) in Cash & Cash Equivalents	-309,611	1,000,426	-68,492
Cash & Cash Equivalents at Beginning of Year	1,042,969	96,476	163,553
Net Cash Flow due to Change in Exchange Rate/Others	-42,074	-53,933	1,415
Cash & Cash Equivalents at End of Year	691,284	1,042,969	96,476
Currency	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - CARsgen Therapeutics Holdings Limited , 02171.HK